Two Sigma Securities, LLC I Bio, Inc. Transaction History

Two Sigma Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.23 - $0.46 $9,057 - $18,114	39,380 New	39,380 $10,000
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $5,234 - $10,643	-17,448 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $607 - $1,149	1,105 Added 6.76%	17,448 $10,000
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $17,323 - $24,841	16,343 New	16,343 $17,000
Q3 2019 Nov 14, 2019	SELL	$0.54 - $0.89 $12,165 - $20,050	-22,529 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.71 - $0.91 $3,767 - $4,828	5,306 Added 30.81%	22,529 $16,000
Q1 2019 May 15, 2019	BUY	$0.75 - $1.0 $12,917 - $17,223	17,223 New	17,223 $15,000
Q4 2018 Feb 14, 2019	SELL	$0.57 - $1.05 $10,941 - $20,155	-19,196 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$0.64 - $0.91 $12,285 - $17,468	19,196 New	19,196 $16,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.